Surrogacy between event-free survival and overall survival in perioperative immunotherapy trials.
623 Background: EFS/DFS are commonly used endpoints in perioperative immune checkpoint inhibitor (ICI) trials, but their reliability as surrogates for overall survival (OS) remains uncertain. For surrogacy to be established there should be strong and consistent correlation between the surrogate and definitive e...